Previous 10 | Next 10 |
ICON Wins Multiple Awards at the 2019 Clinical and Research Excellence Awards ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today announced that it has been awar...
Increasing visibility of potential study participants to sites and sponsors ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced the release of its...
ICON Public Limited Company (ICLR) Q1 2019 Earnings Conference Call May 02, 2019 10:00 AM ET Company Participants Jonathan Curtain – Vice President of Corporate Finance & Investor Relation Brendan Brennan – Chief Financial Officer Steve Cutler – Chief Ex...
Icon (NASDAQ: ICLR ): Q1 GAAP EPS of $1.63 beats by $0.03 . More news on: ICON Public Limited Company, Earnings news and commentary, Healthcare stocks news, Read more ...
Highlights Net business wins (including pass-through) in the quarter of $885 million; a book to bill of 1.31. Closing backlog (including pass-through) of $7.9 billion, a year on year increase of 10.5%. Quarter 1 reported revenue of $675 million. This represents a year on year ...
Gainers: WHR +8.0% . CDNS +5.4% . NEW +4.3% . CMRE +3.9% . GGB +2.6% . More news on: Whirlpool Corporation, Cadence Design Systems, Inc., Puxin Limited, Stocks on the move, Read more ...
ICON recognised for specialised services offering across product development lifecycle ICON plc, (NASDAQ: ICLR) a global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, has won awards across several ca...
Quick Take ICON plc ( ICLR ) has acquired MolecularMD for an undisclosed amount. MolecularMD [MMD] has developed a full service diagnostics service line to accelerate oncology (cancer) drug approval. With the deal for MMD, ICLR gains increased capabilities in the laboratory molecular d...
ICON plc (ICLR) Q4 2018 Earnings Conference Call February 21, 2019 9:00 AM ET Company Participants Jonathan Curtain - Vice President, Corporate Finance & Investor Relations Brendan Brennan - Chief Financial Officer Steve Cutler - Chief Executive Officer Conference Call Par...
News, Short Squeeze, Breakout and More Instantly...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...